UNIPHAR PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.525 EUR | -3.26% |
|
-8.35% | -6.48% |
| Feb. 27 | Uniphar Seeks M&A | CI |
| Feb. 27 | Transcript : Uniphar plc, 2023 Earnings Call, Feb 27, 2024 |
Business Summary
The Company's vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare stakeholders. Uniphar plc represents a strong combination of scale, growth and profitability.
Number of employees: 3,000
Sales per Business
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Uniphar Supply Chain & Retail
67.0
%
| 1,557 | 75.2 % | 1,712 | 67.0 % | +9.93% |
Uniphar Pharma
23.2
%
| - | - | 592 | 23.2 % | - |
Uniphar Medtech
9.8
%
| - | - | 249 | 9.8 % | - |
Sales per region
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Ireland
76.5
%
| 1,765 | 85.2 % | 1,953 | 76.5 % | +10.63% |
Rest of the World
8.1
%
| 163 | 7.9 % | 208 | 8.1 % | +27.09% |
The Netherlands
8.1
%
| - | - | 206 | 8.1 % | - |
United Kingdom
7.3
%
| 142 | 6.9 % | 187 | 7.3 % | +31.42% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Gerard Rabbette
CEO | Chief Executive Officer | - | 10-02-28 |
Tim Dolphin
DFI | Director of Finance/CFO | 60 | 10-06-30 |
Allan Smylie
IRC | Investor Relations Contact | - | - |
Kay Bonavita
PRN | Corporate Officer/Principal | - | 23-08-09 |
Aisling McCarthy
LAW | General Counsel | - | 19-04-30 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Maurice Pratt
CHM | Chairman | - | 03-06-30 |
Tim Dolphin
DFI | Director of Finance/CFO | 60 | 10-06-30 |
Paul Hogan
BRD | Director/Board Member | 64 | 19-06-26 |
Gerard Rabbette
CEO | Chief Executive Officer | - | 10-02-28 |
Sue Webb
BRD | Director/Board Member | - | 19-06-26 |
James Gaul
BRD | Director/Board Member | - | 21-01-25 |
Elizabeth Hoctor
BRD | Director/Board Member | - | 21-01-25 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 273,015,254 | 245,521,313 ( 89.93 %) | 0 | 89.93 % |
Company contact information
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
2.61
EUR
Average target price
4.25
EUR
Spread / Average Target
+62.84%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.33% | 760M | |
| +12.06% | 68.18B | |
| +5.16% | 25.78B | |
| +4.48% | 7.99B | |
| -2.69% | 7.88B | |
| -23.97% | 7.62B | |
| -0.67% | 4.48B | |
| +20.68% | 4.45B | |
| -4.23% | 3.89B | |
| -3.99% | 3.82B |
- Stock Market
- Equities
- UPR Stock
- Company Uniphar plc
